Appointment of Non-Exec

5 Jun 2006 07:00

Phytopharm PLC05 June 2006 Company Contact: U.K. Investor Relations Contact:Phytopharm plc Financial DynamicsDr Richard Dixey David Yates / Ben Atwell +44 207 831 3113+44 7867 782000Dr Daryl Rees+44 1480 437 697www.phytopharm.com Appointment of Non Executive Director GODMANCHESTER, Cambridgeshire, U.K. (June 5 2006) - Phytopharm plc (LSE: PYM;NASDAQBB: PHYOF; PHYOY) ("Phytopharm") announces the appointment with immediateeffect of Mr A D (Sandy) Morrison, former CEO of Lipton Ltd (a Unileversubsidiary) as a Non-executive Board Director of Phytopharm. Mr Morrison (aged 59) has a BSc (Hons) in applied chemistry (Strathclyde) andhas over 20 years experience in general and international management, globalsupply chain and R&D. He was Chief Executive Officer of Lipton Ltd, the globaltea sourcing organization for Unilever with operations in six countries for fiveyears from 2000 to 2006. During Mr Morrison's period as CEO, substantialoperational & financial improvements were made to the Unilever global tea supplychain and he also played a significant part in addressing issues in theinternational tea trade. In the immediate years prior to 2000, Mr Morrison hadsenior international food & beverage roles for Unilever outside the UK, in thesupply chain and in R&D, both at the Rotterdam head office and in the Unileverfood and beverage subsidiary in Australia. Commenting on the appointment, Mr Gordon Stevens, Chairman of Phytopharm, said;"the appointment of a person of this calibre and experience to the Board ofPhytopharm will provide an important asset to the Company and I am delightedthat Sandy will be joining us. This appointment begins a process ofrestructuring of the Board and I look forward to the announcement of furtherappointments in due course." There are no further details required to be disclosed under paragraph 9.6.13R ofthe Listing Rules or Disclosure Rule 3.1.2R. -ENDS- NOTES TO EDITORS Phytopharm plc Phytopharm is a pharmaceutical company with a plant extract division. Thepharmaceutical division is dedicated to the discovery and development of singlechemicals as prescription medicines and the plant extract division is focussedon the development of plant extracts as functional foods and veterinaryproducts.. More information concerning Phytopharm's activities can be found on its web site at http://www.phytopharm.com This information is provided by RNS The company news service from the London Stock Exchange